16.11.2022

News from Ethiopia

Did you know that the Ethiopian FDA has recently issued a new Pharmacovigilance directive?

One of the most important news (among others) is that any market authorization holder of medicines registered in Ethiopia's healthcare market and local representatives have to assign a Qualified Person responsible for Pharmacovigilance (QPPV) in the country and submit official nomination letters to the competent authority.

More news from the weekly PV regulatory intelligence search can be found in iViReg. If you are interested, get in touch with the team via ivireg@ivigee.com to find more news.

Join our monthly email digest

By submitting you agree to our privacy policy.